Red blood cell-derived extracellular vesicles from type 2 diabetes patients induce endothelial dysfunction through a mechanism involving arginase 1

14 April 2024 (09:15 - 09:30)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Aida Collado

Karolinska Institute, Stockholm (Sweden)

3 More presentations in this session

Presentation thumbnail

Extracellular vesicles: straight from the heart

Doctor C. Boulanger (Paris, FR)

Presentation thumbnail

Extracellular vesicles in atherothrombosis

Professor L. Badimon (Barcelona, ES)

Presentation thumbnail

Delivery of mRNA to damaged myocardium by lipid nanoparticles

Associate Professor P. Vader (Utrecht, NL)

Access the full session

Session thumbnail

Extracellular vesicles and cardiovascular disease

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

14 April 2024 09:15 CET

You may be interested in

Congress Presentation

Erythrocyte-derived extracellular vesicles from type 2 diabetes patients induce endothelial dysfunction through arginase 1

26 August 2023

Congress Presentation

Long noncoding RNA H19 is elevated in aortic valve stenosis and governs antigenic response and valvular endothelial cell phenotypes through endothelial to mesenchymal transition

26 August 2023

Congress Presentation

MicroRNAs in circulating microvesicles and plasma as biomarkers that complement the clinical diagnosis of diabetic dyslipidemia and its complications

30 April 2022

Congress Presentation

Cardiac diastolic dysfunction in angiotensin II-treated hypertensive rats is associated with endothelial upregulation of SGLT1/2 in the macro and microcirculation: Protective effect of empagliflozin

29 June 2021

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources